CBIO
#3021
Crescent Biopharma, Inc. - Common Stock
15.2 0 USD
-0.03%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-3.12%
Variación mensual
-14.75%
Variación en los últimos 6 meses
+21.41%
Cambio anual
+18.75%
Cierres anteriores
15.6 9
Open
15.5 0
Mínimo
15.2 0
High
15.5 6
Volumen
62
Financials
- Market Capitalization 419.09 M
- Employee 44
- Founded 2024
- CEO N/A
- Website www.crescentbiopharma.com
- Headquarter Cayman Islands
- FIGI N/A
- Industry Fabricantes de medicamentos — general
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-0.12
Relación precio/flujo de caja
1.75
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 2127 |  MAZE Maze Therapeutics, Inc. - Common Stock | 29.88 USD | +2.40% | -9.01% | +22.81% | -33.64% | 1.65 B USD | ||
| 2854 |  EIKN Eikon Therapeutics, Inc. - Common Stock | 10.19 USD | -2.39% | -12.16% | +7.04% | -40.23% | 551.67 M USD | ||
| 3106 |  UPB Upstream Bio, Inc. - Common Stock | 7.16 USD | -1.65% | -8.91% | +15.67% | -39.32% | 389.65 M USD | ||
| 3236 |  QTTB Q32 Bio Inc. - Common Stock | 18.46 USD | -13.66% | +35.54% | +44.44% | +809.36% | 313.02 M USD |